BG60517B1 - Метод за получаване на соли на 2',3'-дидеоксиинозин монохидрат,2',3'-дидеокси-2',3'-дидехидротимидин моно- хидрат и 2',3'-дидеокси-2'-флуоринозин хемихидрат - Google Patents

Метод за получаване на соли на 2',3'-дидеоксиинозин монохидрат,2',3'-дидеокси-2',3'-дидехидротимидин моно- хидрат и 2',3'-дидеокси-2'-флуоринозин хемихидрат Download PDF

Info

Publication number
BG60517B1
BG60517B1 BG92000A BG9200090A BG60517B1 BG 60517 B1 BG60517 B1 BG 60517B1 BG 92000 A BG92000 A BG 92000A BG 9200090 A BG9200090 A BG 9200090A BG 60517 B1 BG60517 B1 BG 60517B1
Authority
BG
Bulgaria
Prior art keywords
dideoxy
monohydrate
salts
preparation
virus
Prior art date
Application number
BG92000A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG92000A (bg
Inventor
Murray Kaplan
Robert Perrone
Joseph Bogardus
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of BG92000A publication Critical patent/BG92000A/bg
Publication of BG60517B1 publication Critical patent/BG60517B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
BG92000A 1989-05-15 1990-05-14 Метод за получаване на соли на 2',3'-дидеоксиинозин монохидрат,2',3'-дидеокси-2',3'-дидехидротимидин моно- хидрат и 2',3'-дидеокси-2'-флуоринозин хемихидрат BG60517B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35206589A 1989-05-15 1989-05-15
US51426190A 1990-05-01 1990-05-01

Publications (2)

Publication Number Publication Date
BG92000A BG92000A (bg) 1993-12-24
BG60517B1 true BG60517B1 (bg) 1995-07-28

Family

ID=26997373

Family Applications (1)

Application Number Title Priority Date Filing Date
BG92000A BG60517B1 (bg) 1989-05-15 1990-05-14 Метод за получаване на соли на 2',3'-дидеоксиинозин монохидрат,2',3'-дидеокси-2',3'-дидехидротимидин моно- хидрат и 2',3'-дидеокси-2'-флуоринозин хемихидрат

Country Status (16)

Country Link
EP (1) EP0398230B1 (de)
KR (1) KR970001160B1 (de)
CN (2) CN1027896C (de)
AT (1) ATE162528T1 (de)
AU (1) AU617614B2 (de)
BG (1) BG60517B1 (de)
DE (1) DE69031962T2 (de)
DK (1) DK0398230T3 (de)
EG (1) EG19154A (de)
ES (1) ES2113851T3 (de)
FI (1) FI95269C (de)
GR (1) GR3025984T3 (de)
HU (1) HU206628B (de)
IE (1) IE81107B1 (de)
NO (2) NO174102C (de)
PT (1) PT94040B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO920714L (no) * 1991-03-01 1992-09-02 Bristol Myers Squibb Co Tetrahydrofuran-mellomprodukt
US5221611A (en) * 1991-06-19 1993-06-22 Sigma Chemical Company Ddi immunoassays, derivatives, conjugates and antibodies
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
HU217849B (hu) * 1994-01-07 2000-04-28 Merrell Pharmaceuticals Inc. (E)-2'-dezoxi-2'-(fluor-metilén)-citidin monohidrát
EP1765379A4 (de) * 2004-06-17 2009-05-27 Transform Pharmaceuticals Inc Pharmazeutische ko-kristallzusammensetzungen und relevante anwendungsverfahren
JP5485140B2 (ja) 2008-04-10 2014-05-07 浜理薬品工業株式会社 ５−メチルウリジンを出発原料とするエチニルチミジン化合物の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
KR960001372B1 (ko) * 1986-09-24 1996-01-26 예일 유니버시티 레트로비루스로 감염된 환자의 치료에 사용되는 2',3'-디디옥시사이티딘-2'-엔(2',3'-디디옥시-2',3'-디디하이드로사이티딘)의 항생물질
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus
ES2075040T3 (es) * 1988-02-16 1995-10-01 Lilly Co Eli 2',3'-dideoxi-2',2'-difluoronucleosidos.
GB8823319D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
NO176609B (no) 1995-01-23
NO176609C (no) 1995-05-03
EP0398230B1 (de) 1998-01-21
FI902360A0 (fi) 1990-05-11
FI95269C (fi) 1996-01-10
DE69031962T2 (de) 1998-09-17
IE81107B1 (en) 2000-03-08
HU903038D0 (en) 1990-09-28
AU5501190A (en) 1990-11-15
NO902148L (no) 1990-11-16
PT94040A (pt) 1991-01-08
IE901734L (en) 1990-11-15
BG92000A (bg) 1993-12-24
DK0398230T3 (da) 1998-09-21
ES2113851T3 (es) 1998-05-16
CN1047676A (zh) 1990-12-12
HUT53528A (en) 1990-11-28
CN1027896C (zh) 1995-03-15
EP0398230A3 (de) 1991-06-26
AU617614B2 (en) 1991-11-28
PT94040B (pt) 1996-12-31
NO174102B (no) 1993-12-06
DE69031962D1 (de) 1998-02-26
CN1109755A (zh) 1995-10-11
NO902148D0 (no) 1990-05-15
EP0398230A2 (de) 1990-11-22
HU206628B (en) 1992-12-28
EG19154A (en) 1994-09-29
ATE162528T1 (de) 1998-02-15
NO174102C (no) 1994-03-16
NO933367D0 (no) 1993-09-22
NO933367L (no) 1990-11-16
KR970001160B1 (ko) 1997-01-29
KR900017591A (ko) 1990-12-19
FI95269B (fi) 1995-09-29
GR3025984T3 (en) 1998-04-30
CN1057443C (zh) 2000-10-18

Similar Documents

Publication Publication Date Title
FI87783C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2',3'-dideoxinukleosider
US4861759A (en) Antiviral compositions and methods
CA1336088C (en) 1-(3'-substitued-2', 3'-dideoxy-d-ribofuranosyl) thymine and uracil
JPH08501071A (ja) １，５−アンヒドロヘキシトールヌクレオシド類似体および該類似体の医薬としての使用
US5616566A (en) Method of inhibiting HIV replication with 2',3'-dideoxyadenosine
FI91763B (fi) Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi
HUT55028A (en) Process for producing nukleosides and pharmaceutical compositions containing them
BG60517B1 (bg) Метод за получаване на соли на 2',3'-дидеоксиинозин монохидрат,2',3'-дидеокси-2',3'-дидехидротимидин моно- хидрат и 2',3'-дидеокси-2'-флуоринозин хемихидрат
PT85755B (pt) Processo para a preparacao de 2',3'-didesoxicitidineno-2' (2',3'-didesoxi-2',3'-didesidrocitidina) utilizavel no tratamento de pacientes infectados com retrovirus
US4920210A (en) 2,6-diaminopurine-9-β-D-2',3'-dideoxyribofuranoside
AU5691094A (en) Dihydropyrimidine nucleosides with antiviral properties
JP2926257B2 (ja) 抗ウイルス性で高い水溶性を持ち且つ安定な結晶性２′，３′‐ジデオキシイノシン・モノ水和物塩、２′，３′‐ジデオキシ‐２′，３′‐ジデヒドロチミジン・モノ水和物塩及び２′，３′‐ジデオキシ‐２′‐フルオロイノシン・ヘミ水和物塩
US6207650B1 (en) Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
RU2073007C1 (ru) Способ получения устойчивой водорастворимой кристаллической соли 2,3-дидеоксиинозина
WO2024103979A1 (zh) 一种抑制疱疹病毒的化合物
CZ237290A3 (cs) Ve vodě vysoce rozpustné, stabilní krystalické soli 2`,3`-dideoxyinosinu, 2`,3`-dideoxy-2`,3`-didehydrothymidinu a 2`,3`-dideoxy-2`-fluorinosinu
JPH02247191A (ja) 抗レトロウイルス剤としてのプリンおよびピリミジン非環状ヌクレオシドの環状モノホスフエート類
EP0617046A1 (de) Nucleosidderivate und Antiherpes-Zusammensetzung
EP0294113A1 (de) Therapeutische Nucleoside
JPH013197A (ja) 抗ウイルス化合物およびそれを含有する抗ウイルス剤
JPH06263756A (ja) イソヌクレオシド誘導体